| |
| |
|
| Insider
Information: |
Winningham Rick E |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,688,476 |
|
|
Indirect Shares
|
96,467 |
|
|
| Direct
Value |
$31,541,999 |
|
|
|
Indirect Value
|
$896,178 |
|
|
| Total
Shares |
2,784,943 |
|
|
| Total
Value |
$32,438,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-05-15 |
1,852,641 |
2024-05-15 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-09-12 |
4 |
AS |
$40.03 |
$894,791 |
D/D |
(22,353) |
690,106 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-11-20 |
4 |
D |
$36.40 |
$365,674 |
D/D |
(10,046) |
680,060 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2014-02-20 |
4 |
D |
$39.98 |
$371,694 |
D/D |
(9,297) |
670,763 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-04-17 |
4 |
AS |
$140.00 |
$3,850,000 |
D/D |
(27,500) |
13,587 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2014-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
82,500 |
753,263 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2014-05-09 |
4 |
D |
$26.86 |
$1,349,044 |
D/D |
(50,225) |
703,038 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
156,200 |
859,238 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2014-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
62,403 |
921,641 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
15,237 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-08-12 |
4 |
S |
$133.15 |
$144,734 |
D/D |
(1,087) |
14,150 |
0 |
- |
|
| INVA |
Innoviva Inc |
Director |
– • – |
2014-08-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(96,250) |
825,391 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2014-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
57 |
521,638 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
521,581 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2015-02-20 |
4 |
D |
$19.52 |
$28,890 |
D/D |
(1,480) |
520,158 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2015-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,310 |
15,460 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2015-08-10 |
4 |
S |
$179.98 |
$144,178 |
D/D |
(801) |
14,659 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2015-08-14 |
4 |
B |
$11.79 |
$744,421 |
D/D |
63,140 |
583,298 |
2.81 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2015-08-17 |
4 |
B |
$12.13 |
$204,512 |
D/D |
16,860 |
602,056 |
2.81 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
280,000 |
882,056 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2016-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,365 |
16,024 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2016-08-15 |
4 |
S |
$136.45 |
$86,373 |
D/D |
(633) |
15,391 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2016-11-20 |
4 |
D |
$31.96 |
$267,186 |
D/D |
(8,360) |
875,399 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
903,399 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2017-02-20 |
4 |
D |
$33.78 |
$1,123,658 |
D/D |
(33,264) |
870,135 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2017-05-20 |
4 |
D |
$36.83 |
$569,392 |
D/D |
(15,460) |
856,377 |
0 |
- |
|
131 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
